| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Jerome J. Lande is Director at ITRI and has filed Form 4s across 2 companies. Jerome J. Lande's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.3M at current prices.
Historically, Jerome J. Lande's trades have earned a below-average insider score of 37/100 across 3 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -5.6%.
The biggest single holding is ITRI (~$1.1M) as Director. The ITRI filings lean toward selling, a net 14,896 shares.
Jerome J. Lande has 36 Form 4 filings on record from June 2015 to October 2026, across 2 companies: Director at Itron (ITRI), 2021–2026; Director at Conmed (CNMD), 2015–2024.
The 51 reported transactions were 24 stock awards, 12 option or other derivative awards, 7 option exercises and 6 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $64.7M.
The largest open-market sale was 1,630,800 shares of CNMD at an average $38.28 on February 19, 2016, about $62.4M.